Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Study of Fampridine-ER Tablets in Patients With Multiple Sclerosis

ClinicalTrials.gov ID: NCT01328379

Public ClinicalTrials.gov record NCT01328379. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:51 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of Two Doses of Oral Dalfampridine Extended Release Tablets (5 mg and 10 mg Twice Daily) in Patients With Multiple Sclerosis

Study identification

NCT ID
NCT01328379
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Acorda Therapeutics
Industry
Enrollment
430 participants

Conditions and interventions

Interventions

  • Dalfampridine-ER 5mg Drug
  • Dalfampridine-ER 10mg Drug
  • Placebo Other

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 28, 2011
Primary completion
Mar 31, 2012
Completion
Jun 30, 2012
Last update posted
Sep 4, 2013

2011 – 2012

United States locations

U.S. sites
70
U.S. states
31
U.S. cities
62
Facility City State ZIP Site status
North Central Neurology Associates, PC Cullman Alabama
Phoenix Neurological Associates, Ltd Phoenix Arizona
Arizona Neurological Institute Sun City Arizona
Clinical Research Advantage Inc. Tempe Arizona
Sutter East Bay Physicians Medical Foundation Berkeley California
Neuro-Pain Medical Center, Inc. Fresno California
Loma Linda University Medical Center Loma Linda California
Collaborative NeuroScience Network, Inc. Long Beach California
University of California Davis Medical Center Sacramento California
Mount Sinai Rehabilitation Hospital Hartford Connecticut
Georgetown University Hospital Washington D.C. District of Columbia
Neurology Associates, PA Maitland Florida
University of Miami School of Medicine, Dept. of Neurology Miami Florida
Neurological Associates Pompano Beach Florida
Neurologique Foundation, Inc. Ponte Vedra Florida
Negroski, Sutherland and Hanes Neurology Sarasota Florida
Suncoast Neuroscience Associates, Inc. St. Petersburg Florida
Tallahassee Neurological Clinic, PA Tallahassee Florida
Axiom Clinical Research of Florida Tampa Florida
The Multiple Sclerosis Center of Vero Beach Vero Beach Florida
Sheperd Center, Inc. Atlanta Georgia
Northwestern University Chicago Illinois
Consultants in Neurology Ltd. Northbrook Illinois
Indiana University School of Medicine Indianapolis Indiana
Josephson Wallack Munshower Neurology, PC Indianapolis Indiana
Methodist Plaza Specialty Des Moines Iowa
Ruan Neurology Clinic and Research Center Des Moines Iowa
The University of Kansas Medical Center Kansas City Kansas
Associates in Neurology, PSC Lexington Kentucky
University of Maryland, Maryland Center for Multiple Sclerosis Baltimore Maryland
Lahey Clinic Lexington Massachusetts
Springfield Neurology Associates, LLC Springfield Massachusetts
Wayne State University Detroit Michigan
Advanced Neurology Specialists Great Falls Montana
Veterans Administration Sierra Neveda Health Care System Reno Nevada
Upstate Clinical Research, LLC Albany New York
NYU Langone Medical Center MS Comprehensive Care Center New York New York
Comprehensive Multiple Sclerosis Care Center at South Shore Neurologic Associates Patchogue New York
Island Neurological Associates, PC Plainview New York
University of Rochester Medical Center Rochester New York
PMG Research of Charlotte Charlotte North Carolina
The Neurological Institute, PA Charlotte North Carolina
PMG Research of Hickory, LLC Hickory North Carolina
Raleigh Neurology Associates Raleigh North Carolina
PMG Research of Winston-Salem Winston-Salem North Carolina
Altru Health System Clinic Grand Forks North Dakota
Northern Ohio Neuroscience, LLC Bellevue Ohio
Cleveland Clinic Foundation Cleveland Ohio
Neurological Research Institute Columbus Ohio
Ohio State University, Columbus Columbus Ohio
Neurology Specialists, Inc. Dayton Ohio
OMRF Multiple Sclerosis Center of Excellence Oklahoma City Oklahoma
Oregon Health and Science University Portland Oregon
Providence Multiple Sclerosis Center Portland Oregon
The Pennsylvania State University, Milton S. Hershey Medical Center Hershey Pennsylvania
Hospital of the University of Pennsylvania Philadelphia Pennsylvania
Temple University School of Medicine Philadelphia Pennsylvania
The Neurology Foundation, Inc. Providence Rhode Island
Wesley Neurology Clinic, PC Cordova Tennessee
Advanced Neurosciences Institute Franklin Tennessee
Sibyl E. Wray, MD, Neurology, PC Knoxville Tennessee
Texas Neurology, PA Dallas Texas
Kelsey-Seybold Clinic Houston Texas
Maxine Mesinger Multiple Sclerosis Clinic; Baylor College of Medicine Houston Texas
Fletcher Allen Health Care Burlington Vermont
Hampton Roads Neurology Newport News Virginia
Neurological Associates Richmond Virginia
Virginia Commonwealth University Richmond Virginia
Swedish Neuroscience Institute Seattle Washington
Aurora Saint Luke's Medical Center Milwaukee Wisconsin

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01328379, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Sep 4, 2013 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01328379 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →